Publication | Open Access
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial
72
Citations
44
References
2021
Year
Fatty Liver DiseaseRandomized Phase 2ObesityMetabolic SyndromeInflammationNonalcoholic Fatty Liver DiseaseInflammatory MarkersHealth SciencesAllergyLiver PhysiologyChronic InflammationHepatology InflammationPharmacologyDrug-induced Liver InjuryAnti-inflammatoryHepatologyNafld ReducesLiver DiseaseMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1